Disorders of Purine and Pyrimidine Metabolism Basic and Clinical Considerations
Author:
Seegmiller J. Edwin
Reference292 articles.
1. Ackerman, J. J. H., Grove, T. H., Wong, G. G., Gadian, D. G., and Radda, G. K., 1980, Mapping of metabolites in whole animals by 31P NMR using surface coils, Nature 283:167–170. 2. Agudelo, C. A., Weinberger, A., Schumacher, H. R., Turner, R., and Molina, J., 1979, Definitive diagnosis of gout by identification of urate crystals in asymptomatic metatarsophalangeal joints, Arthritis Rheum. 22:559–560. 3. Ahmed, F. E., and Setlow, R. B., 1978, Excision repair in ataxia telangiectasia, Fanconi’s anemia, Cockayne syndrome, and Bloom’s syndrome after treatment with ultraviolet radiation and N-acetoxy-2-acetylaminofluorene, Biochim. Biophys. Acta 521:805–817. 4. Allsop, J., and Watts, R. W., 1980, Activities of amidophosphoribosyltransferase (E.C. 2.4.2.14) and the purine phosphoribosyltransferases (E.G. 2.4.2.7 and E.C. 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development—their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome, J. Neurol. Sci. 46:221–232. 5. Ames, B. N., Cathcart, R., Schwiers, E., and Hochstein, P., 1981, Uric acid: An antioxidant defense in humans against oxidant- and radical-caused aging and cancer. A hypothesis, Proc. Natl. Acad. Sci. U.S.A. 78:6858–6862.
|
|